Accelerate Diagnostics Inc. Finalizes Asset Sale Amidst Chapter 11 Liquidation Process
Accelerate Diagnostics, Inc. has finalized an asset sale as part of its Chapter 11 liquidation process. The U.S. Bankruptcy Court confirmed the company's restructuring plan on August 13, 2025. The agreement with Indaba Capital Management involves selling specific assets and liabilities, with the effective date expected around August 18, 2025. This move is part of the Amended and Restated Asset Purchase Agreement, aimed at implementing the outlined transactions.
Accelerate Diagnostics, Inc., along with its US subsidiary Accelerate Diagnostics Texas, LLC, has reached a significant milestone in its restructuring process. On August 13, 2025, the United States Bankruptcy Court for the District of Delaware confirmed the Second Amended Combined Disclosure Statement and Chapter 11 Plan of Liquidation. The company has entered into an agreement with an affiliate of Indaba Capital Management, L.P., its existing secured noteholder, to sell certain assets and liabilities. This move, part of the Amended and Restated Asset Purchase Agreement, modifies the initial agreement to focus on specific assets. The company anticipates the Plan’s Effective Date to be around August 18, 2025, as it aims to implement the transactions outlined in the Plan. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Accelerate Diagnostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-079855), on August 18, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
